ASX - By Stock
|
EXL |
Re:
News: EXL Elixinol Wellness Reconfirms FY24 Revenue Guidance Of A$16M - A$20M
|
|
Fen52
|
2 |
747 |
2 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
2
|
747
|
2
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Fen52
|
13 |
5.9K |
0 |
31/10/22 |
31/10/22 |
ASX - By Stock
|
13
|
5.9K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
Fen52
|
2 |
786 |
0 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
2
|
786
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Full Year Statutory Accounts
|
|
Fen52
|
6 |
2.6K |
1 |
31/08/22 |
31/08/22 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Merger Proposal Update
|
|
Fen52
|
28 |
8.8K |
5 |
15/02/22 |
15/02/22 |
ASX - By Stock
|
28
|
8.8K
|
5
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Investor presentation
|
|
Fen52
|
16 |
5.2K |
1 |
04/02/22 |
04/02/22 |
ASX - By Stock
|
16
|
5.2K
|
1
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Investor presentation
|
|
Fen52
|
16 |
5.2K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
16
|
5.2K
|
2
|
|
ASX - By Stock
|
EXL |
Re:
EXL bottomed out
|
|
Fen52
|
19 |
13K |
2 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
19
|
13K
|
2
|
|
ASX - By Stock
|
EXL |
Re:
EXL bottomed out
|
|
Fen52
|
19 |
13K |
2 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
19
|
13K
|
2
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Quarterly update and Appendix 4C
|
|
Fen52
|
22 |
5.3K |
1 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
22
|
5.3K
|
1
|
|
ASX - By Stock
|
LKO Energy |
Re:
Can you purchase 10,000,000 shares or more or can you order twice?
|
|
Fen52
|
6 |
2.8K |
1 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
6
|
2.8K
|
1
|
|
ASX - By Stock
|
LKO |
Re:
20th Jan, the revised date of offer...LOL..
|
|
Fen52
|
20 |
5.2K |
1 |
20/01/22 |
20/01/22 |
ASX - By Stock
|
20
|
5.2K
|
1
|
|
ASX - By Stock
|
LKO |
Re:
Offer opens on 18th, website is now open
|
|
Fen52
|
25 |
6.8K |
2 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
25
|
6.8K
|
2
|
|
ASX - By Stock
|
GSS |
Re:
Ann: 3base SARS-CoV-2 kit registered by TGA for saliva samples
|
|
Fen52
|
17 |
5.2K |
3 |
17/01/22 |
17/01/22 |
ASX - By Stock
|
17
|
5.2K
|
3
|
|
ASX - By Stock
|
GSS |
Re:
News: GSS Genetic Signatures Expects Sales Of At Least A$21M For Half Year
|
|
Fen52
|
30 |
8.4K |
0 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
30
|
8.4K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
Ann: Chairman's Address to Shareholders
|
|
Fen52
|
55 |
12K |
3 |
09/12/21 |
09/12/21 |
ASX - By Stock
|
55
|
12K
|
3
|
|
ASX - By Stock
|
GSS Medicine |
Re:
Confused
|
|
Fen52
|
36 |
65K |
0 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
36
|
65K
|
0
|
|
ASX - By Stock
|
GSS Medicine |
Confused
|
|
Fen52
|
36 |
65K |
0 |
25/10/21 |
25/10/21 |
ASX - By Stock
|
36
|
65K
|
0
|
|
ASX - By Stock
|
GSS |
Re:
How Long Until Valudation????
|
|
Fen52
|
2 |
831 |
0 |
24/03/20 |
24/03/20 |
ASX - By Stock
|
2
|
831
|
0
|
|
ASX - By Stock
|
GSS |
How Long Until Valudation????
|
|
Fen52
|
2 |
831 |
0 |
23/03/20 |
23/03/20 |
ASX - By Stock
|
2
|
831
|
0
|
|